There has been recent activity by the Food and Drug Administration (“FDA”) that could have far reaching consequences for the Hemp CBD industry, and may provide a foreshadowing of what’s to come if and when we see federal cannabis legalization:
- A guidance entitled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research” was released last week.
- A proposal entitled “Cannabidiol Enforcement Policy” was sent to the Office of Management and Budget that may lay out the guidelines for the distribution and sale of products containing CBD.
Since the FDA is likely to play a regulatory hand in regulating “marijuana” if and when it is descheduled or rescheduled, cannabis operators should be paying as close attention to these documents as hemp-derived CBD businesses.
DISCLAIMER: THIS INFORMATION IS STRICTLY EDUCATIONAL AND DOES NOT CONSTITUTE LEGAL ADVICE.